Ares Genetics - an OpGen Group Company - is developing DNA-based infectious disease services and solutions for drug response prediction to improve the way antimicrobial resistant (AMR) infections are diagnosed, and prevented or treated.
Our innovative AI-powered and Machine Learning (ML) driven approach leverages the extensive, curated database ARESdb to comprehensively detect and determine the genetic profile of pathogens.
Unlike conventional molecular assays, Ares Genetics solutions not only detect AMR markers but shed light on prevalence and diagnostic performance for these markers and predict how pathogens will respond to therapy.
Imprint: https://www.ares-genetics.com/imprint
Please follow OpGen, our parent company, for updates.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Karl-Farkas-Gasse 18, Vienna,1030,austria
- co****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- IT services, Molecular Diagnostics, Molecular Epidemiology, Biomarker Discovery & Licensing, Data Solutions, Next Generation Sequencing, Assay Development, (Pre)-Clinical Solutions, Companion Diagnostics, Outbreak Monitoring, Antimicrobial Stewardship, Functional Analyses, Artificial Intelligence, Antimicrobial Resistance (AMR), Sequencing Services.
- HQ
- Vienna
Ares Genetics Questions
Ares Genetics's LinkedIn profile is https://at.linkedin.com/company/ares-genetics
Ares Genetics has
2 employees.
View email and phone details for 2
employees at Ares Genetics.
Ares Genetics's industry is
Biotechnology Research
Ares Genetics's top competitors are
Ribbon Bio,
Apeiron Biologics Ag,
Aitiologic,
Myllia Biotechnology,
Lexogen,
Hookipa Pharma Inc.,
Proxygen,
Opgen, Inc.,
Curetis Gmbh,
Evercyte Gmbh.
Ares Genetics's support email address is contact@ares-genetics.com
Ares Genetics's categories are Biotechnology Research
Ares Genetics's founding year is 2017
